Tesamorelin 20mg
Tesamorelin (GHRH analogue)
Tesamorelin is a synthetic GHRH analogue with extended half-life. The 20mg vial provides extended supply for long-duration GH secretion and visceral adiposity research protocols.
For Research Use Only
Not for human consumption, veterinary use, or any therapeutic applications.
Purity
Purity Exceeds 99%
Storage
36-46°F (2-8°C)
Origin
Made in USA
Documentation
COA Available
Procurement Information
This product is available exclusively to qualified research institutions and licensed facilities through authorized distribution channels.
- Valid research credentials required
- Orders processed through authorized agents only
- End-user certification documentation required
Research Mechanisms
- GHRH receptor agonist with extended half-life
- Stimulates endogenous GH secretion from anterior pituitary
- Reduces visceral adipose tissue in research models
- Modulates IGF-1 levels downstream
- Body composition regulation research
Research Background
- FDA approved as Egrifta for HIV-associated lipodystrophy
- Clinical research on visceral fat reduction
- Studies on GH axis restoration
- Investigations into metabolic syndrome models
Storage & Handling
Recommended Storage Conditions
Store at 36–46°F (2–8°C). Protect from light. Do not freeze.
- - Keep away from direct sunlight
- - Maintain consistent temperature
- - Check expiration date before use
- - Reconstituted peptides: use within 28 days

